• 11/14/2024

The FTC challenged hundreds of pharmaceutical patent listings in an effort to encourage generics, including for blockbusters such as Ozempic and Victoza.

Wall Street Journal

The FTC challenged hundreds of pharmaceutical patent listings in an effort to encourage generics, including for blockbusters such as Ozempic and Victoza.

https://www.wsj.com/health/pharma/ftc-patents-ozempic-insulin-a2f5cee5